Puma Biotechnology Inc
General
Total Cases2
Active Cases--
Patents--
Ratings
Experience
Grade
Trend
DCT
--
--
--
PTAB
--
--
--
CAFC
--
--
--
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 09/17/24 | NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re [522] Notice of Appeal (Federal Circuit) filed by Wyeth LLC. USCA Case Number 24-2325 (jfm) (Entered: 09/17/2024) | |
| 09/12/24 | NOTICE OF APPEAL to the Federal Circuit of [517] Judgment,, [516] Memorandum and Order . Appeal filed by Wyeth LLC. (Dellinger, Megan) (Entered: 09/12/2024) | |
| 09/12/24 | APPEAL - Credit Card Payment received re [522] Notice of Appeal (Federal Circuit) filed by Wyeth LLC. ( Filing fee $605, receipt number ADEDC-4497024.) (Dellinger, Megan) (Entered: 09/12/2024) | |
| 09/12/24 | Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re [522] Notice of Appeal (Federal Circuit). (mpb) (Entered: 09/12/2024) | |
| 09/04/24 | OBJECTIONS by Wyeth LLC to [519] Bill of Costs . (Dellinger, Megan) (Entered: 09/04/2024) | |
| 08/21/24 | DECLARATION re 519 Bill of Costs [Declaration of Melissa Keech in Support of AstraZeneca's Bill of Costs] by AstraZeneca AB, AstraZeneca PLC, AstraZeneca Pharmaceuticals, LP. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(DiBenedetto, Emily) (Entered: 08/21/2024) | |
| 08/21/24 | BILL OF COSTS by AstraZeneca AB, AstraZeneca Pharmaceuticals, LP. (DiBenedetto, Emily) (Entered: 08/21/2024) | |
| 08/15/24 | FINAL Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,603,314 B2; 10,596,162 B2. (mpb) (Entered: 08/15/2024) | |
| 08/14/24 | FINAL JUDGMENT in favor of AstraZeneca AB and AstraZeneca Pharmaceuticals, LP on Counts 1 and 2 of the complaint by Plaintiff Wyeth LLC. Judgment is entered in favor of Wyeth LLC on Counts 1, 3, and 5 of AstraZeneca's Counterclaim. Judgment is entered in favor of AstraZeneca on Counts 2 and 4 of its counterclaim based on a determination that claims 1, 3, and 9 of the '314 patent and claim 1 of the '162 patent are invalid under 35 U.S.C. § 112 for lack of enablement and lack of written description. The non-final judgment entered on May 28, 2024 (dkt. 463 ) is vacated.This is a final and appealable judgment. (CASE CLOSED) Signed by Judge Matthew F Kennelly on 8/14/2024. (mpb) (Entered: 08/14/2024) | |
| 08/14/24 | FINAL JUDGMENT in favor of AstraZeneca AB and AstraZeneca Pharmaceuticals, LP on Counts 1 and 2 of the complaint by Plaintiff Wyeth LLC. Judgment is entered in favor of Wyeth LLC on Counts 1, 3, and 5 of AstraZeneca's Counterclaim. Judgment is entered in favor of AstraZeneca on Counts 2 and 4 of its counterclaim based on a determination that claims 1, 3, and 9 of the '314 patent and claim 1 of the '162 patent are invalid under 35 U.S.C. § 112 for lack of enablement and lack of written description. The non-final judgment entered on May 28, 2024 (dkt. 463 ) is vacated.This is a final and appealable judgment. (CASE CLOSED) Signed by Judge Matthew F Kennelly on 8/14/2024. (mpb) (Entered: 08/14/2024) |